Ebrantil and Bradycardia - a phase IV clinical study of FDA data

Summary:

Bradycardia is reported as a side effect among people who take Ebrantil (urapidil), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Clopidogrel, and have Urination - painful.

The phase IV clinical study analyzes which people have Bradycardia when taking Ebrantil. It is created by eHealthMe based on reports of 1,650 people who have side effects when taking Ebrantil from the FDA, and is updated regularly.

What is Ebrantil?

Ebrantil has active ingredients of urapidil. eHealthMe is studying from 1,656 Ebrantil users. Check the latest studies of Ebrantil.

What is Bradycardia?

Bradycardia (abnormally slow heart action) is found to be associated with 1,930 drugs and 3,118 conditions by eHealthMe. Check the latest studies of Bradycardia.

On Jul, 17, 2026

1,650 people reported to have side effects when taking Ebrantil.
Among them, 31 people (1.88%) have Bradycardia.

Among these 31 people:

How long have people been on Ebrantil when they have Bradycardia? *

What is the gender of people who have Bradycardia when taking Ebrantil? *

female: 74.07 %
male: 25.93 %

What is the age of people who have Bradycardia when taking Ebrantil? *

What are other drugs people take besides Ebrantil? *

What are other side effects people have besides Bradycardia? *

Hypotension (abnormally low blood pressure): 10 people, 32.26%
Arrhythmias (irregular heartbeat): 6 people, 19.35%
Weakness: 5 people, 16.13%
Atrioventricular Block Second Degree (heart block second degree): 5 people, 16.13%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 16.13%
Dizziness: 5 people, 16.13%
Suicide Attempt: 4 people, 12.90%
Hyperkalemia (damage to or disease of the kidney): 4 people, 12.90%
Nausea (feeling of having an urge to vomit): 4 people, 12.90%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 3 people, 9.68%

What are the existing conditions these people have? *

Urination - Painful: 4 people, 12.90%
High Blood Pressure: 3 people, 9.68%
Osteoporosis (bones weak and more likely to break): 2 people, 6.45%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 6.45%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 6.45%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 6.45%
Gastritis (inflammation of stomach): 2 people, 6.45%
Chronic Kidney Disease: 1 person, 3.23%
Constipation: 1 person, 3.23%
Endometrial Cancer: 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Ebrantil and have Bradycardia?

- Check whether Bradycardia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ebrantil:

Ebrantil (1,656 reports)

Bradycardia treatments and more:

Bradycardia (61,180 reports)

Browse all side effects of Ebrantil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bradycardia:

Bradycardia (1,930 drugs)

Browse all the conditions that are associated with Bradycardia:

Bradycardia (3,118 conditions)

Related publications that referenced our studies

Schlumbrecht MP, Hehr K, "Cisplatin-induced bradycardia and the importance of the QT interval", Journal of Oncology Pharmacy Practice, 2015 Jan .
Oflaz MB, Kucukdurmaz Z, Guven AS, Karapinar H, Kaya A, Sancakdar E, Deveci K, Gul I, Erdem A, Cevit O, Icagasioglu FD, "Bradycardia seen in children with Crimean-Congo hemorrhagic fever", Vector-Borne and Zoonotic Diseases, 2013 Nov .
Schlumbrecht MP, Hehr K, "Cisplatin-induced bradycardia and the importance of the QT interval", Journal of Oncology Pharmacy Practice, 2015 Jan .
Oflaz MB, Kucukdurmaz Z, Guven AS, Karapinar H, Kaya A, Sancakdar E, Deveci K, Gul I, Erdem A, Cevit O, Icagasioglu FD, "Bradycardia seen in children with Crimean-Congo hemorrhagic fever", Vector-Borne and Zoonotic Diseases, 2013 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on urapidil (the active ingredients of Ebrantil) and Ebrantil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.